Abbott to buy St. Jude for $25 billion to boost heart devices
(Reuters) - Abbott Laboratories said on Thursday that it would buy St. Jude Medical Inc in a $25 billion deal to expand its heart device business, but investors worried that the acquisition would not pay off as promised.
No comments:
Post a Comment